BDTX-189
BDTX-189 is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations (KDs of 0.2, 0.76, 13 and 1.2 nM for EGFR, HER2, BLK and RIPK2, reapectively) . BDTX-189 exhibits anticancer activity.
Product Specifications
CAS Number
2414572-47-5
Purity
>98% (HPLC)
Solubility
DMSO:41.67 mg/mL (74.27 mM; Need ultrasonic)
Smiles
C=CC (=O) NC1=C (C=C2C (=C1) C (=NC=N2) NC3=CC (=C (C=C3) OCC4=CC=CC=N4) Cl) OCCN5CCOCC5
Molecular Formula
C29H29ClN6O4
Molecular Weight
561.03
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
042578-ML405 100 µL
TAF1D, NT (TAF1D, JOSD3, TATA box-binding protein-associated factor RNA polymerase I subunit D, RNA polymerase I-specific TBP-associated factor 41kD, TATA box-binding protein-associated factor 1D, Transcription initiation factor SL1/TIF-IB subunit D) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
RR204129L4V 200 µL
Acadsb (NM_013084) Rat Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details